Skip to content
Saturday, November 14, 2026
Scotia Arena UK

Giving Pluripotent Cells During Pregnancy to Infants with Neural Tube Defect Boosts Life Outcomes, Research Shows

A pioneering medical trial has discovered that delivering regenerative cells to unborn babies suffering from spina bifida during corrective surgery could constitute a "important advancement" in treating birth defects.

Research Framework and Assurance

The US-based trial involved six developing infants with myelomeningocele. Surgeons applied regenerative cells sourced from the maternal placenta on the exposed area of the infant's spine during the repair procedure.

Importantly, the cell therapy was found to be safe. Doctors verified that the cells did not cause tumors, hinder surgical recovery, or prevent the reversal of associated brain abnormalities.

Encouraging Results

Imaging conducted after delivery confirmed a complete reversal of brainstem displacement in all six infants. This favorable anatomical change is strongly associated with better mobility and function.

"In the event it allows more children capable of walking who otherwise would not, then it would become the conventional approach," commented the principal investigator. "The results are extremely promising and pave the way for numerous possible innovative interventions."

Future Implications and Hope

Independent medical specialists proposed that subsequent studies of these observed advantages could announce a "new era" in fetal surgery. The prospect of enhancing neurological damage seen in utero is regarded as a paradigm-shifting aim.

Notably important would be improvements in bladder and bowel function, which are common challenges for people affected by this disorder.

Looking Ahead

Despite this being a first-in-human effort was small in scale, its safety demonstration and positive signals create a solid basis for larger, more comprehensive studies. The combination of regenerative medicine with established fetal surgery techniques presents significant potential for transforming outcomes for infants diagnosed prenatally with this neural tube defect.

JS
About the author

John Stone

Elena is a sports journalist and event coordinator with over a decade of experience covering UK venues and entertainment.

Scotia Arena UK

Type to search articles.